⌘K
t
Anita Hyman, a person closely associated with BioPharma Credit PLC Director Harry Hyman, purchased 151 ordinary shares of BioPharma Credit PLC. This transaction, acquired as part of dividend reinvestment, occurred on 30 October 2024 at a price of £0.66582 per share on the London Stock Exchange.
| Date | 4 Nov 2024 |
| Time | 12:16:49 |
| Category | Director/PDMR dealings |
| ID | 8457K |
BIOPHARMA CREDIT PLC
Notification of Transactions by
Persons Discharging Managerial Responsibilities and
Persons Closely Associated with them
|
1. |
Details of person discharging managerial responsibilities/person closely associated with them |
||||||
|
a) |
Name |
Anita Hyman |
|||||
|
2. |
Reason for the notification |
||||||
|
a) |
Position / status |
Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC) |
|||||
|
b) |
Initial notification / amendment |
Initial notification |
|||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
|
a) |
Name |
BioPharma Credit PLC |
|||||
|
b) |
LEI |
213800AV55PYXAS7SY24 |
|||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
|
a) |
Description of the financial instrument
Identification Code |
Ordinary Shares of $0.01 each
GB00BDGKMY29 |
|||||
|
b) |
Nature of the transaction |
Purchase of Shares (acquired as part of dividend reinvestment) |
|||||
|
c) |
Price(s) and volume(s) |
|
|||||
|
d) |
Aggregated information - Aggregated volume
- Price |
N/A
|
|||||
|
e) |
Date of the transaction |
30.10.2024 |
|||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|||||